Page last updated: 2024-10-28

hydralazine and Osteoporosis

hydralazine has been researched along with Osteoporosis in 2 studies

Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.

Osteoporosis: Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jacobs, RP1
Hart, FD1

Other Studies

2 other studies available for hydralazine and Osteoporosis

ArticleYear
Drug-induced rheumatic diseases.
    Comprehensive therapy, 1984, Volume: 10, Issue:8

    Topics: Adrenal Cortex Hormones; Anticonvulsants; Antineoplastic Agents; Diuretics; Gout; Heparin; Humans; H

1984
Drug-induced arthritis.
    Current medical research and opinion, 1974, Volume: 2, Issue:9

    Topics: Acute Disease; Anticoagulants; Antihypertensive Agents; Arteritis; Arthritis; Barbiturates; Contrace

1974